These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro. Miller MD; Anton KE; Mulato AS; Lamy PD; Cherrington JM J Infect Dis; 1999 Jan; 179(1):92-100. PubMed ID: 9841827 [TBL] [Abstract][Full Text] [Related]
10. FDA grants tentative approval to first generic version of antiretroviral Viread. AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039 [No Abstract] [Full Text] [Related]
11. Tenofovir: FDA hearing on important new antiretroviral. James JS AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411 [No Abstract] [Full Text] [Related]
12. FDA notifications. Tenofovir in India receives tentative approval. AIDS Alert; 2009 Jun; 24(6):70-1. PubMed ID: 19544609 [No Abstract] [Full Text] [Related]
13. FDA notifications. Tentative approval of generic lamivudine. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112 [No Abstract] [Full Text] [Related]
19. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too]. MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303 [No Abstract] [Full Text] [Related]
20. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1. Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]